An international study has identified 11 new gene alterations connected to more aggressive prostate cancer using a simple blood test. The discovery could improve treatments for prostate cancer by ...

A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one of the most prevalent ...

This year, due to the COVID-19 pandemic and social distancing requirements, the PMEA Awards event will be streamed live at pmlive.com/pmea2020. After receiving a high ...

A wide range of top-performing healthcare comms agencies, charities and healthcare communicators claimed the honours at last night’s annual Communiqué Awards. The awards, run every year by PMLive’s ...

Merck & Co is closing on a new indication for its checkpoint inhibitor Keytruda in early bladder cancer in the US, following a positive vote by an FDA expert panel. The Oncologic Drugs Advisory ...

BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...

Pfizer and Clear Creek Bio have announced a collaboration aiming to advance the discovery and development of novel papain-like protease (PLpro) inhibitors and potentially introduce a new class of oral ...

French pharma company Servier and biopharma company Oncodesign have reach the first milestone in their collaboration on research and development into new drug candidates for Parkinson’s disease. In a ...

A new COVID-19 subvariant, XBB.1.5, is causing concern in the US, where it has been spreading rapidly since December. Data from the US Centers for Disease Control and Prevention (CDC) has estimated ...

The European Commission (EC) has approved Roche’s highly anticipated haemophilia treatment Hemlibra (emicizumab). The rare bleeding disorder treatment, which is cleared in the EU for routine ...

The American Medical Association (AMA) has urged the US Food and Drug Administration (FDA) to work with the medical community to provide transparency around COVID-19 vaccines currently in development.

The European Union is demanding that AstraZeneca (AZ) delivers 120 million doses of its COVID-19 vaccine by the end of June, threatening financial sanctions if the company fails to meet this target.